142
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Comparing asthma control assessment using the Asthma Control Test and the Asthma APGAR in African American/Black and Hispanic/Latinx populations

, MD, MSc, , MPH, , PhD, , MD, , MPH, , MD & , MD, MS show all
Pages 1592-1600 | Received 25 Oct 2022, Accepted 27 Dec 2022, Published online: 02 Feb 2023

References

  • US Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute. National Asthma Education Prevention Panel. Guidelines for the Diagnosis and Management of Asthma Summary Report 2007. 2012. Available from: https://www.nhlbi.nih.gov/health-topics/guidelines-fordiagnosis-management-of-asthma [last accessed 22 May 2022].
  • Cloutier MM, Baptist AP, Blake KV, Brooks EG, Bryant-Stephens T, DiMango E, Dixon AE, Elward KS, Hartert T, Krishnan JA, et al.; Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC). 2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol 2020;146(6):1217–1270. doi:10.1016/j.jaci.2020.10.003.
  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2021. Available from: https://ginasthma.org/gina-reports/ [last accessed 22 May 2022].
  • Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, et al.; American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180(1):59–99. doi:10.1164/rccm.200801-060ST.
  • Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14(4):902–907. doi:10.1034/j.1399-3003.1999.14d29.x.
  • Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113(1):59–65. doi:10.1016/j.jaci.2003.09.008.
  • Skinner EA, Diette GB, Algatt-Bergstrom PJ, Nguyen TT, Clark RD, Markson LE, Wu AW. The asthma therapy assessment questionnaire (ATAQ) for children and adolescents. Dis Manag 2004;7(4):305–313. doi:10.1089/dis.2004.7.305.
  • Yawn BP, Bertram S, Wollan P. Introduction of Asthma APGAR tools improve asthma management in primary care practices. J Asthma Allergy 2008;1:1–10. doi:10.2147/jaa.s3595.
  • Yawn BP, Wollan PC, Rank MA, Bertram SL, Juhn Y, Pace W. Use of Asthma APGAR tools in primary care practices: a cluster-randomized controlled trial. Ann Fam Med 2018;16(2):100–110. doi:10.1370/afm.2179.
  • Murphy KR, Chipps B, Beuther DA, Wise RA, McCann W, Gilbert I, Eudicone JM, Gandhi HN, Harding G, Coyne KS, et al.; US PRECISION Advisory Board. Development of the asthma impairment and risk questionnaire (AIRQ): a composite control measure. J Allergy Clin Immunol Pract 2020;8(7):2263–2274.e5. doi:10.1016/j.jaip.2020.02.042.
  • van Dijk BCP, Svedsater H, Heddini A, Nelsen L, Balradj JS, Alleman C. Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature review. BMC Pulm Med 2020;20(1):79. doi:10.1186/s12890-020-1090-5.
  • Alzahrani YA, Becker EA. Asthma control assessment tools. Respir Care 2016;61(1):106–116. doi:10.4187/respcare.04341.
  • Melosini L, Dente FL, Bacci E, Bartoli ML, Cianchetti S, Costa F, Di Franco A, Malagrinò L, Novelli F, Vagaggini B, et al. Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control. J Asthma 2012;49(3):317–323. doi:10.3109/02770903.2012.661008.
  • Yawn BP, Rank MA, Cabana MD, Wollan PC, Juhn YJ. Adherence to asthma guidelines in children, tweens, and adults in primary care settings: a practice-based network assessment. Mayo Clin Proc 2016;91(4):411–421. doi:10.1016/j.mayocp.2016.01.010.
  • Mold JW, Fox C, Wisniewski A, Lipman PD, Krauss MR, Harris DR, Aspy C, Cohen RA, Elward K, Frame P, et al. Implementing asthma guidelines using practice facilitation and local learning collaboratives: a randomized controlled trial. Ann Fam Med 2014;12(3):233–240. doi:10.1370/afm.1624.
  • Rank M, Bertram SB, Wollan P, Yawn RA, Yawn BP. Comparing the Asthma APGAR system and the asthma control test in a multicenter primary care sample. Mayo Clin Proc 2014;89(7):917–925. doi:10.1016/j.mayocp.2014.02.016.
  • Gold DR, Wright R. Population disparities in asthma. Annu Rev Public Health 2005;26:89–113. doi:10.1146/annurev.publhealth.26.021304.144528.
  • Gupta RS, Carrión-Carire V, Weiss KB. The widening Black/White gap in asthma hospitalizations and mortality. J Allergy Clin Immunol 2006;117(2):351–358. doi:10.1016/j.jaci.2005.11.047.
  • Rose D, Mannino DM, Leaderer BP. Asthma prevalence among US adults, 1998–2000: role of Puerto Rican ethnicity and behavioral and geographic factors. Am J Public Health 2006;96(5):880–888. doi:10.2105/AJPH.2004.050039.
  • Leong AB, Ramsey CD, Celedón JC. The challenge of asthma in minority populations. Clin Rev Allergy Immunol 2012;43(1):56–83.
  • Hall T, Rooks R, Kaufman C. Intersections of adverse childhood experiences, race and ethnicity and asthma outcomes: findings from the behavioral risk factor surveillance system. IJERPH. 2020;17(21):8236. doi:10.3390/ijerph17218236.
  • Mersha TB, Beck AF. The social, economic, political, and genetic value of race and ethnicity in 2020. Hum Genomics 2020;14(1):37. Erratum in: Hum Genomics. 2020 Nov 24;14(1):42. doi:10.1186/s40246-020-00284-2.
  • Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 1998;114(4):998–1007. doi:10.1378/chest.114.4.998.
  • Israel E, Cardet JC, Carroll JK, Fuhlbrigge AL, Pace WD, Maher NE, She L, Rockhold FW, Fagan M, Forth VE, et al. A randomized, open-label, pragmatic study to assess reliever-triggered inhaled corticosteroid in African American/Black and Hispanic/Latinx adults with asthma: design and methods of the PREPARE trial. Contemp Clin Trials 2021;101:106246. doi:10.1016/j.cct.2020.106246.
  • Israel E, Cardet J-C, Carroll JK, Fuhlbrigge AL, She L, Rockhold FW, Maher NE, Fagan M, Forth VE, Yawn BP, et al. Reliever-triggered inhaled glucocorticoid in Black and Latinx adults with Asthma. N Engl J Med 2022;386(16):1505–1518. doi:10.1056/NEJMoa2118813.
  • Bime C, Wei CY, Holbrook JT, Sockrider MM, Revicki DA, Wise RA. Asthma symptom utility index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients. J Allergy Clin Immunol 2012;130(5):1078–1084. doi:10.1016/j.jaci.2012.07.058.
  • Haun J, Noland Dodd VJ, Graham-Pole J, Rienzo B, Donaldson P. Testing a health literacy screening tool: implications for utilization of a BRIEF health literacy indicator. Fed Pract. 2009;26:24–31.
  • Chan AHY, Vervloet M, Lycett H, Brabers A, van Dijk L, Horne R. Development and validation of a self-report measure of practical barriers to medication adherence: the medication practical barriers to adherence questionnaire (MPRAQ). Br J Clin Pharmacol 2021; 87(11):4197–4211. doi:10.1111/bcp.14744.
  • Stone JK, Shafer LA, Graff LA, Lix L, Witges K, Targownik LE, Haviva C, Sexton K, Bernstein CN. Utility of the MARS-5 in assessing medication adherence in IBD. Inflamm Bowel Dis 2021;27(3):317–324. doi:10.1093/ibd/izaa056.
  • Evans JD. 1996. Straightforward statistics for the behavioral sciences. Pacific Grove, CA: Thomson Brooks/Cole Publishing Co.
  • Kritikos V, Price D, Papi A, Infantino A, Ställberg B, Ryan D, Lavorini F, Chrystyn H, Haughney J, Lisspers K, et al. A multinational observational study identifying primary care patients at risk of overestimation of asthma control. NPJ Prim Care Respir Med 2019;29(1):43. Published 2019 Dec 5.
  • Schatz M, Hsu JW, Zeiger RS, Chen W, Dorenbaum A, Chipps BE, Haselkorn T. Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2014;133(6):1549–1556. doi:10.1016/j.jaci.2013.10.006.
  • Cajigal S, Wells KE, Peterson EL, Ahmedani BK, Yang JJ, Kumar R, Burchard EG, Williams LK. Predictive properties of the Asthma Control Test and its component questions for severe asthma exacerbations. J Allergy Clin Immunol Pract 2017;5(1):121–127.e2. doi:10.1016/j.jaip.2016.06.025.
  • Kwon JW, Jung H, Kim SH, Chang YS, Cho YS, Nahm DH, Jang AS, Park JW, Yoon HJ, Cho SH, et al.; COREA investigators. High ACT score is not sufficient to reduce the risk of asthma exacerbations in asthma with low lung function. Respir Med 2019;150:38–44. doi:10.1016/j.rmed.2019.02.010.
  • Ko FWS, Hui DSC, Leung T-F, Chu H-Y, Wong GWK, Tung AHM, Ngai JCN, Ng SSS, Lai CKW. Evaluation of the Asthma Control Test: a reliable determinant of disease stability and a predictor of future exacerbations. Respirology 2012;17(2):370–378. doi:10.1111/j.1440-1843.2011.02105.x.
  • Kosinski M, Nelsen L, Rizio AA, Lay-Flurrie J, von Maltzahn R, Jacques L, Schatz M, Stanford RH, Svedsater H. Psychometric properties of the Asthma Control Test in 2 randomized clinical trials. J Allergy Clin Immunol Pract 2021;9(1):561–563.e1.
  • Chipps BE, Murphy KR, Wise RA, McCann WA, Beuther DA, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, et al. Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recall. Ann Allergy Asthma Immunol 2022;128(5):544–552.e3. doi:10.1016/j.anai.2022.01.035.
  • Lurbet MF, Rojano B, Whittaker Brown SA, Busse P, Holguin F, Federman AD, Wisnivesky JP. Obesity trends among asthma patients in the United States: a population-based study. Ann Glob Health 2019;85(1):10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.